Publication date: 2016

DOI: 10.1016/j.jacc.2016.03.116

Bioresorbable vascular scaffolds (BVS) have shown their safety and applicability in series of clinical trials. According to these studies number of adverse outcomes comparable with adverse outcomes of modern drug eluted stents. Presumably, these adverse outcomes driven by undiagnosed malaposition and inadequate predilation. This hypothesis is indirectly confirmed by fact that most adverse effects occur within three weeks after bioresorbable vascular scaffold implantation. Previous publications have shown that regardless careful following manufacturer instructions, optical coherence tomography (OCT) founds indications for further BVS optimization in 25-40%. Aim of our study was to found, whether OCT after BVS implantation influence long term clinical outcome.

Тип: Article